Rise Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-15
Closed -$3.18K – 676
2023
Q3
$3.18K Hold
15
– – ﹤0.01% 416
2023
Q2
$2.89K Hold
15
– – ﹤0.01% 474
2023
Q1
$3.04K Hold
15
– – ﹤0.01% 517
2022
Q4
$1.93K Hold
15
– – ﹤0.01% 573
2022
Q3
$2K Hold
15
– – ﹤0.01% 583
2022
Q2
$3K Hold
15
– – ﹤0.01% 528
2022
Q1
$2K Hold
15
– – ﹤0.01% 571
2021
Q4
$2.32K Buy
+15
New +$2.51K ﹤0.01% 515

Other funds holding SGEN

Rise Advisors's SGEN Position: Q4 2023 in Review

Rise Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 15 shares — an estimated $3.18K sold.

Rise Advisors first reported a position in SGEN in Q4 2021 and held it in 8 quarters. The position peaked at $3.18K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Rise Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Rise Advisors sold 15 Seagen Inc. Common Stock shares in Q4 2023, an estimated $3.18K.
  • Rise Advisors first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Rise Advisors's Seagen Inc. Common Stock position peaked at $3.18K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Rise Advisors's 13F filing for Q4 2023, filed 10 Jan 2024.